Janus kinase 2 (JAK2) is a non-receptor tyrosine kinase that regulates signaling pathways through MPL, TpoR, EpoR, etc. JAK2 is crucial for normal hematopoiesis and JAK2V617F mutation is found in 2–5% of MDS cases. Here, MPL is linked to myelodysplastic syndrome.